EpistrySign in
LimitedMetadata only — full assessment not yet run

Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line

Allison B. Coffin, Emily Dale, Emilee Doppenberg, Forrest W. Fearington, Tamasen Hayward, Jordan Hill, Olivia Molano · Frontiers in Cellular Neuroscience · 2022

DOI 10.3389/fncel.2022.941031

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (Frontiers in Cellular Neuroscience). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationcited
    • Cited by 13 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in Frontiers in Cellular Neuroscience.
    • Publisher: Frontiers Media.
    • ISSN 1662-5102.
    • The journal is listed in DOAJ.
    • Open-access status: gold.
Assessed by Epistry · metadata as of August 23, 2026
Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and iverm… — Epistry